Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial.

Keywords

Geography

References

• Atherosclerosis--an inflammatory disease.Francine Pellaud — 1999
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group — 1998
• Rabbit model for Chlamydia pneumoniae infectionI. W. Fong, B Chiu, Esther Viira — 1997
• Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis.Wandy L. Beatty, Robert Morrison, G I Byrne — 1994
• Discrete sequential boundaries for clinical trialsK. K. Gordon Lan, David L. DeMets — 1983
• Azithromycin-induced block of elementary body formation in Chlamydia trachomatisJoanne N. Engel — 1992
• The in-vitro antibiotic susceptibility of Chlamydia pneumoniae.Lynda Fenelon, G Mumtaz, G.L. Ridgway — 1990
• Rationale for the Use of Azithromycin as Mycobacterium avium ChemoprophylaxisMichael W. Dunne, George Foulds, James A. Retsema — 1997
• Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patientsMatthias Maass, Jens Gieffers, E. Tobias Krause — 1998
• Inhalation of levomepromazine in severe acute asthma.Johan Pedersen, Annette Olsen, Adrian Banning — 1994
• Low Density Lipoprotein Oxidation and Its Pathobiological Significance*Daniel Steinberg — 1997
• High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors.Jens Boman, Stefan Söderberg, Julie Forsberg — 1998
• Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertensionFred Lacy, Daniel T. O’Connor, Geert W. Schmid‐Schönbein — 1998
• Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.Pekka Saikku, Kari Mattila, Markku S. Nieminen — 1988
• Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial.Edward C. Oldfield, W. Jeffrey Fessel, Michael W. Dunne — 1998
• Infections caused by Chlamydia pneumoniae strain TWAR.J. Thomas Grayston — 1992
• In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniaeMargaret R. Hammerschlag, K K Qumei, P M Roblin — 1992
• Treatment of Chlamydia pneumoniae infection in adult asthma: a before-after trial.David L. Hahn — 1995
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)Anders Olsson, John J.V. McMurray, G Thorgeirsson — 1994
• Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979.M. B. Aldous, J. Thomas Grayston, S.-p. Wang — 1992

Cited by

• Cardiac protection by pharmacological modulation of inflammation史秀 村山, 頌 高野, 菊野 村山 — 2001
• Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarctionU. Burkhardt, Ralf Zahn, U. H�ffler — 2004
• Chlamydia pneumoniae: detection and geotyping of infections in atherosclerotic carotid arteriesM. Cochrane — 2004
• Avaliação dos efeitos antitrombótico e antiinflamatório da roxitromicina : experimento randomizado em coelhosPitágoras Pinto Scipioni — 2004
• Infection and Inflammation in progression of Atherosclerosis : the role of Chlamydiae pneumoniae infection in different mouse modelsRajaa Ezzahiri — 2007
• Die Wirkung von Roxithromycin auf die Prognose von Patienten mit Koronardilatation bei koronarer HerzerkrankungAntje Haar — 2004
• Adverse events in people taking macrolide antibiotics versus placebo for any indication.Malene Plejdrup Hansen, Anna Mae Scott, Amanda McCullough — 2015
• Novel PCR-EIA method for the detection of Chlamydia pneumoniae in respiratory specimens.John Inman-Bamber, Charles Wan, Tim Gardam — 2002
• Emerging concepts in disease management: a role for antimicrobial therapy in coronary artery diseaseSteven Girard, Zelalem Temesgen — 2001
• Antibiotics for vascular diseases: a meta-analysis of randomized controlled trials.Kachi Illoh, Orieji C. Illoh, Habteab B. Feseha — 2005
• Chlamydia pneumoniae and Atherosclerosis: No Way-Out or Long Way?George Tsirpanlis — 2004
• Recurrent pneumonia due to persistent Chlamydia pneumoniae infection.Naoyuki Miyashita, Hiroshi Fukano, Hiroki Hara — 2002
• Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease.David Aguilar, Marian R. Fisher, Christopher M. O’Connor — 2006
• Anti-inflammatory effects of macrolide antibiotics.Ognjen Čulić, Vesna Eraković Haber, Michael J. Parnham — 2001
• Antibiotic use and risk of ischemic stroke in the elderly.José A. Luchsinger, Ariel Pablos-Méndez, Charles Knirsch — 2001
• Inflammation and coronary artery disease.Alice Y. Tiong, David Brieger — 2005
• Chlamydia pneumoniae and atherosclerosisRobert J. Belland, Scot P. Ouellette, Jens Gieffers — 2004
• Use of antibiotics is not associated with decreased risk of myocardial infarction among patients with diabetes.Andrew J. Karter, David H. Thom, Jennifer Y. Liu — 2003
• Azithromycin inhibits interleukin-6 but not fibrinogen production in hepatocytes infected with cytomegalovirus and chlamydia pneumoniae.John J. M. Bouwman, Frank L.J. Visseren, Paul K Bouter — 2004
• Multiple Infections and Subsequent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) StudyMarek Smieja, Judy Gnarpe, Eva Lonn — 2003

Related papers

No related papers recorded.